Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Rheumatology News celebrates 20 years
Rheumatology News’ first issue was published in February 2002, and in 2022 we’ll be taking a look back at rheumatology’s past and ahead to its...
News
Lilly calls it quits on baricitinib’s development for lupus
The company said it is stopping phase 3 trials because of disappointing results.
News
FDA approves risankizumab (Skyrizi) for psoriatic arthritis
The approval is the second indication for the anti–interleukin-23 monoclonal antibody after clearance for plaque psoriasis was granted in 2019.
News
Tofacitinib approved for new ankylosing spondylitis indication
The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.
News
Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication
The drug was previously approved for rheumatoid arthritis.
News
Adalimumab biosimilar Cyltezo gets interchangeability designation
The approval of the supplemental biologics license application for Cyltezo makes the adalimumab biosimilar just the second biosimilar to be...
News
Temporary hold of mycophenolate helps immune response to SARS-CoV-2 vaccination
A comparison of patients with rheumatic and musculoskeletal diseases shows that withholding mycophenolate around the time of vaccination can be...
News
European agency recommends two new adalimumab biosimilars
The Committee for Medicinal Products for Human Use gave a positive opinion for the approval of Hukyndra and Libmyris, each of which will have 15...
News
Low RA flare rate reported after Pfizer COVID vaccination
The rate of flares seen among RA patients in remission after vaccination was in line with other reports across a range of rheumatic and...
News
NIH to study COVID vaccine booster in people with autoimmune disease
The trial will look at the impact of a booster in patients with five different autoimmune diseases who are either on or off immunosuppressives.
News
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
News
Dan Kastner wins Crafoord Prize in Polyarthritis
Dr. Kastner received the award for identifying the mechanisms responsible for familial Mediterranean fever, tumor necrosis factor receptor–...
News
High-need, high-cost lupus patients described for first time
The identification of this group “will help pave the way to develop programs that improve the quality of care for high-risk lupus patients,”...